REVLIMID 5 mg, gélule
gélule
orale
Autorisation active
Procédure centralisée
Commercialisée
6/14/2007
BRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
Business Listing - September 04, 2021
This is a premium business listing. Stand out from the competition!